References
- Andersen A. P., Nesbakken R., Hatlevoll R., Lindgren S., Notter G., Hagen S., Holme I., Kollevold T., Kristiansen K., Torvik A., Brun A., Lindgren M., Elgen K. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation, Lack of potentiation of Bleomycin on survival time. A prospective multicenter trial of the Scandinavian Glioblastoma Study Group. To be published in Cancer
- Berdal P. Head and neck carcinoma. Treatment with Bleomycin and radiation. Gann Monograph on Cancer Res. 1976; 19: 133
- Bäckström A., Jakobsson P. Å., Littbrand B., Wersäll J. Fractionation scheme with low individual doses in irradiation of carcinoma of the mouth. Acta radiol. Ther. Phys. Biol. 1973; 12: 401
- Cachin Y., Jortay A., Sancho H., Eschwege F., Madelain M., Desaulty A., Gerard P. Preliminary results of a randomized E.O.R.T.C. study comparing radiotherapy and concomitant Bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx. Europ. J. Cancer 1977; 13: 1389
- Denekamp J. Tumour regression as a guide to prognosis. A study with experimental animals. Brit. J. Radiol. 1977; 50: 271
- Edsmyr F. Combined treatment with Bleomycin in penile carcinomas. Gann Monograph on Cancer Res. 1976; 19: 231
- Ellis F. Dose, time and fractionations. A clinical hypothesis. Clin. Radiol. 1969; 20: 1
- Hansen H. S., Rygård J., Engelhom S. A. Clinical use of combined Bleomycin and radiation therapy for head and neck tumours and testicular cancers. Bull. Cancer 1976; 63: 371
- Jakobsson P. Å., Littbrand B. Fractionation scheme with low individual tumour dose and high total tumour dose. Acta radiol. Ther. Phys. Biol. 1973; 12: 337
- Kirk J., Gray W. M., Watson E. R. Cumulative radiation effect. Part I. Fractionated treatment regimes. Clin. Radiol. 1971; 22: 145
- Matsuzawa T., Onozawa M., Morita K., Kakehi M. Radiosensitization of Bleomycin on lethal effect of mouse cancer cell in vitro. Strahlentherapie 1972; 144: 614
- Midander J., Littbrand B., Edsmyr F. Irradiation combined with Bleomycin treatment of synchronized cells in culture under oxic and hypoxic conditions. Acta radiol. Oncology 1980; 19: 395
- Mäntylä M., Kortekangas A. E., Valavaara R. A., Nordman E. M. Tumour regression during radiation treatment as a guide to prognosis. Brit. J. Radiol. 1979; 52: 972
- Sakamoto K. The effect of Bleomycin and its combined effect with radiation on cultured Chinese hamster cells V‐79. Europ. J. Cancer 1978; 14: 309
- Shanta V., Krishnamurthi S. The combined therapy or oral cancer. Gann Monograph on Cancer Res. 1976; 19: 159
- Shrieve C. D., Harris J. W. Effects of Bleomycin and irradiation on euoxic and hypoxic cells. Int. J. Radiat. Oncol. Biol. Phys. 1979; 5: 1495
- Terasima T., Takabe Y., Yasukawa M. Combined effect on X‐ray and Bleomycin on cultured mammalian cells. Gann 1975; 66: 701
- Terasima T., Watanabe M., Takabe Y., Miyamoto A. Action of Bleomycin on proliferative capacity of mammalian cells. Gann Monograph on Cancer Res. 1976; 19: 157
- Twentyman P. R., Bleehen N. M. The sensitivity of cells in exponential and stationary phases of growth to Bleomycin and to 1.3‐bis (2‐chloroethyl) 1‐nitrosourea. Brit. J. Cancer 1973; 28: 500
- Urano M., Fukuda N., Koike S. The effect of Bleomycin on survival and tumour growth in a C3H mouse mammary carcinoma. Cancer Res. 1973; 33: 2849